VERA THERAPEUTICS INC (VERA:NASDAQ)
$34.34 0.3 (0.8813%)
Analysed VERA THERAPEUTICS INC (VERA:NASDAQ) News Sources
High-Flying Biotech Stock Up 360% Faces $48 Million Trim but Remains This Fund's Largest Holding
21-03-2026
fool.com
Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer
25-03-2026
yahoo.com
These 5 Biotechs Could Be the Next Big GLP-1 Acquisition Target
01-04-2026
247wallst.com
Is Vera Therapeutics (VERA) Still Attractive After An 87% One Year Share Price Surge
10-04-2026
yahoo.com
IgA Nephropathy Market Forecast to 2036: Novel Therapies and Key Growth Drivers Fuel Expansion | DelveInsight
29-04-2026
yahoo.com
Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference
04-05-2026
yahoo.com
Vera Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
07-05-2026
yahoo.com
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08-05-2026
yahoo.com
The Bull Case For Vera Therapeutics (VERA) Could Change Following Atacicept’s FDA Priority Review And Ramp-Up
11-05-2026
yahoo.com
Investment Firm Closes Out Entire $18.1 Million Position in Biotech Stock, According to Latest SEC Filing
26-05-2026
fool.com
What is the current price of VERA THERAPEUTICS INC (VERA:NASDAQ)?
The current price of VERA THERAPEUTICS INC (VERA:NASDAQ) is $34.34.
VERA THERAPEUTICS INC (VERA:NASDAQ) absolute price change since previous trading day?
The absolute price change of VERA THERAPEUTICS INC (VERA:NASDAQ) since the previous trading day is $0.3.
VERA THERAPEUTICS INC (VERA:NASDAQ) percentage price change since previous trading day?
The percentage price change of VERA THERAPEUTICS INC (VERA:NASDAQ) since the previous trading day is 0.8813%.
What is the most recent average sentiment score for VERA THERAPEUTICS INC (VERA:NASDAQ)?
The most recent average sentiment score for VERA THERAPEUTICS INC (VERA:NASDAQ) is 87 out of 100.
What is the most recent average sentiment for VERA THERAPEUTICS INC (VERA:NASDAQ)?
The most recent sentiment for VERA THERAPEUTICS INC (VERA:NASDAQ) is .
SEC-8K** Filing Available For VERA THERAPEUTICS INC (VERA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.